IMAC Holdings logo
IMAC Holdings IMAC

Quarterly report 2025-Q2
added 08-14-2025

report update icon

IMAC Holdings Financial Statements 2011-2025 | IMAC

Annual Financial Statements IMAC Holdings

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.51 M 1.07 M 905 K 30.2 M 17.1 M 9.15 M - - - - - - - -

Shares

1.57 M 1.11 M 942 K 22.6 M 10.2 M 7.75 M - - - - - - - -

Historical Prices

0.96 0.96 0.96 1.34 1.68 1.1 - - - - - - - -

Net Income

-9.05 M -9.42 M -18.3 M -10.5 M -5.54 M -6.5 M -3.05 M -57.2 K -381 K - - - - -

Revenue

72 K - - 14.4 M 12.8 M 15.1 M 6.7 M 786 K 15 K - - - - -

Cost of Revenue

305 K - - - - - - - - - - - - -

Gross Profit

-233 K - - - 12.8 M 12.6 M 5.77 M 723 K 10.7 K - - - - -

Operating Income

-5.62 M -6.38 M -11.8 M -10.1 M -6.54 M -6.19 M -3.55 M - - - - - - -

Interest Expense

- -2.04 K 3.15 K 504 K 563 K 259 K 154 K - - - - - - -

EBITDA

-5.48 M -5.97 M -10.2 M -8.45 M -4.75 M -4.63 M -2.9 M -849 K -397 K - - - - -

Operating Expenses

5.39 M 6.38 M 11.8 M 24.5 M 19.3 M 18.8 M 9.32 M 1.64 M 230 K - - - - -

General and Administrative Expenses

5.39 M 2.94 M 2.47 M 6.42 M 4.56 M 16 M 7.81 M 1.45 M 205 K - - - - -

All numbers in USD currency

Quarterly Income Statement IMAC Holdings

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

3.78 M 3.15 M 2.03 M 1.91 M 1.18 M 1.15 M 1.15 M 1.11 M 1.1 M 1.1 M 1.1 M 914 K 26.8 M 26.4 M 26.2 M 25.3 M 25.1 M 13.4 M 12.7 M 11.8 M 10.2 M 9.61 M 8.91 M 8.37 M 8.11 M 5.92 M 4.53 M 4.53 M 4.53 M 4.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-2.12 M -2.2 M - -2.2 M -1.38 M -407 K - -2.86 M -1.4 M -3.7 M - -6.33 M -1.84 M -3.16 M - -2.89 M -2.54 M -2.23 M - -1.47 M -1.98 M -2.07 M - -1.55 M -1.9 M -1.6 M - -980 K -732 K -405 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- 1.5 K - 56.3 K 15.8 K - - 1.57 M 1.34 M 2.09 M - 3.79 M 5.03 M 3.89 M - 3.49 M 3.47 M 3.06 M - 3.48 M 2.57 M 3.32 M - 4.36 M 3.76 M 2.77 M - 2.53 M 635 K 268 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

102 K 103 K - 122 K 72 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

-102 K -102 K - -65.8 K -56.3 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-1.97 M -2.19 M - -2 M -1.4 M -409 K - -3.26 M -1.14 M -1.3 M - -6.35 M -1.8 M -3.14 M - -2.79 M -2.41 M -2.05 M - -1.31 M -1.71 M -1.99 M - -1.64 M -2.11 M -1.34 M - -1.21 M -918 K -584 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - 40.5 K - 71.8 K 22.4 K 846 - 2.98 K 4.73 K 4.13 K - 108 K 126 K 176 K - 141 K 135 K 76.2 K - 74.5 K 85.2 K 30.7 K - 45.8 K 32.7 K 23.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-1.92 M -2.14 M - -1.94 M -1.37 M - - -3.22 M -1.05 M -1.11 M - -5.86 M -1.36 M -2.7 M - -1.47 M -1.55 M -1.63 M - -878 K -1.26 M -1.54 M - -1.22 M -1.71 M -1.06 M - -788 K -829 K -553 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

1.87 M 2.09 M - 1.93 M 1.35 M 409 K - 3.26 M 1.14 M 1.3 M - 10.1 M 6.83 M 7.04 M - 6.27 M 5.88 M 5.12 M - 4.79 M 4.28 M 5.32 M - 5.99 M 5.87 M 4.11 M - 3.74 M 1.55 M 852 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

1.87 M 2.09 M - 1.93 M 1.35 M 409 K - 997 K 836 K 603 K - 1.87 M 1.86 M 1.82 M - 1.6 M 1.66 M 1.22 M - 962 K 1.21 M 1.24 M - 1.31 M 1.43 M 977 K - 1 M 737 K 240 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements IMAC Holdings IMAC
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting IMAC Holdings plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
American Shared Hospital Services American Shared Hospital Services
AMS
$ 2.11 1.44 % $ 13.7 M usaUSA
Мать и Дитя Мать и Дитя
MDMG
- - - russiaRussia
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
$ 10.28 0.39 % $ 2.34 B usaUSA
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 4.12 -7.62 % $ 540 M chinaChina
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 21.32 0.24 % $ 10.5 B usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 23.53 0.64 % $ 7.05 B germanyGermany
Hanger Hanger
HNGR
- - $ 732 M usaUSA
Community Health Systems Community Health Systems
CYH
$ 3.24 -1.37 % $ 428 M usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 483.48 0.23 % $ 132 B usaUSA
Chemed Corporation Chemed Corporation
CHE
$ 428.21 -0.22 % $ 6.43 B usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 14.2 -1.73 % $ 1.3 B usaUSA
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
$ 16.38 0.68 % $ 642 M usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
$ 138.84 0.79 % $ 2.14 B usaUSA
The Joint Corp. The Joint Corp.
JYNT
$ 8.74 -2.67 % $ 127 M usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
Option Care Health Option Care Health
OPCH
$ 33.18 0.85 % $ 5.69 B usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 114.75 0.34 % $ 1.95 B usaUSA
The Ensign Group The Ensign Group
ENSG
$ 175.65 0.86 % $ 9.95 B usaUSA
The Pennant Group The Pennant Group
PNTG
$ 29.85 1.15 % $ 931 M usaUSA
Encompass Health Corporation Encompass Health Corporation
EHC
$ 106.94 0.08 % $ 10.7 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 6.8 -2.09 % $ 459 M britainBritain
MEDNAX MEDNAX
MD
$ 22.27 0.72 % $ 1.86 B usaUSA
DaVita DaVita
DVA
$ 121.59 1.05 % $ 10.3 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 19.34 -0.36 % $ 1.43 B usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 40.21 -1.35 % $ 1.63 B usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
$ 15.3 -0.94 % $ 1.91 B usaUSA
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 80.6 0.22 % $ 1.21 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 25.99 7.84 % $ 215 M usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Surgery Partners Surgery Partners
SGRY
$ 15.56 -3.23 % $ 1.95 B usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 199.26 0.78 % $ 19.3 B usaUSA
Universal Health Services Universal Health Services
UHS
$ 222.38 -0.98 % $ 14.8 B usaUSA
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA